(Massive Bio and CureMatch have joined forces in a transformative partnership aimed at revolutionizing cancer treatment. The partnership accelerates the drug development process, offers faster access to advanced therapies, and aims to reduce dispariti...
BELLEVUE, Wash.--(BUSINESS WIRE)--#CurvaFix--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of a $39 million equity financing led by MVM Partners with participation from Sectoral Asset Mana...
Wavely's latest investment brings total funding to date to $6.35MM, propels their mission to revolutionize pediatric care by enabling widespread access to effective treatment anytime, anywhere, from a smartphone appSEATTLE--(BUSINESS WIRE)--Wavely Dia...
Over 100 Hospitals Use Vital’s Total Experience Management Applications To Deliver More Personalized, Understandable, Accessible, and Relevant Care ExperiencesCLAYMONT, Del.--(BUSINESS WIRE)--Vital, a leading artificial intelligence (AI)-driven digita...
XLerateHealth (XLH), a nationally recognized healthcare accelerator headquartered in Louisville, KY, with a second location in Flint, MI, today announced the selection of eight startup companies to participate in the 2023 flagship accelerator program.
DALLAS--(BUSINESS WIRE)--#digitalhealth--Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health outcomes approach, today announces...
Now Accepting Proposals for Disruptive Ideas That Address the Most Pressing Issues Across the Healthcare LandscapePLEASANTON, Calif.--(BUSINESS WIRE)--#AI--CharmHealth, a leading provider of healthcare technology solutions, today announced the launch ...
Survey offers insights into how health plans and employers can circumvent these barriers BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a leader in hybrid care enablement, released results of a survey that asked employed U.S. adults about their experi...
First prescription digital behavioral therapeutic device delivering novel form of cognitive behavioral therapy via smartphone In a randomized controlled trial AspyreRx demonstrated clinically meaningful and statistically significant durable reductions...
Enabling a time-efficient workflow and better-informed clinical decision making for structural heart interventionsGENT, Belgium--(BUSINESS WIRE)--FEops announced today its new release of FEops HEARTguide™, including an AI-based anatomical analysis of ...